Press Releases

2015/11/9

ScinoPharm Changshu Site Completed US FDA Inspection

ScinoPharm (TWSE:1789) today announced that its subsidiary, ScinoPharm Changshu, located in the Changshu Economic Development Zone in Jiangsu Province, China, has successfully completed a cGMP inspection by the US FDA with no resulting 483 concerns or comments.